SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:liu-200959"
 

Search: id:"swepub:oai:DiVA.org:liu-200959" > IgA vasculitis neph...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

IgA vasculitis nephritis-outcomes in adult-onset disease

Stanway, James (author)
Royal Free Hosp, England
Brown, Nina (author)
Salford Royal Fdn Trust, England
Pervez, Afeera (author)
Queen Elizabeth Hosp, England
show more...
van de Perre, Els (author)
Addenbrookes Hosp, England
Tollitt, James (author)
Salford Royal Fdn Trust, England
Marketos, Nikolaos, 1976- (author)
Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten
Wong, Nikki (author)
Imperial Coll London, England
Dhaygude, Ajay (author)
Royal Preston Hosp, England
Ponnusamy, Arvind (author)
Royal Preston Hosp, England
O'Riordan, Ed (author)
Salford Royal Fdn Trust, England
Venning, Michael (author)
Manchester Royal Infirm, England
Segelmark, Marten (author)
Lund Univ, Sweden
Morgan, Matthew (author)
Queen Elizabeth Hosp, England
Jayne, David (author)
Addenbrookes Hosp, England
Hamilton, Patrick (author)
Manchester Royal Infirm, England
Pusey, Charles D. (author)
Imperial Coll London, England
Oni, Louise (author)
Alder Hey Childrens NHS Fdn Trust Hosp, England
Salama, Alan D. (author)
Royal Free Hosp, England
show less...
 (creator_code:org_t)
2024
2024
English.
In: Rheumatology. - : OXFORD UNIV PRESS. - 1462-0324 .- 1462-0332.
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives: IgA vasculitis (IgAV) in adults has been relatively under-investigated. Since outcomes are worse in other forms of vasculitis with increasing age, we investigated the outcomes of IgAV comparing younger adults (18-34), middle-aged adults (35-64) and elderly patients (>= 64 years) focusing on kidney outcomes. Methods: We identified patients with renal biopsy-confirmed IgAV nephritis and collected data regarding clinical features and progression to end stage kidney disease (ESKD). The relationship between patient factors and ESKD was analysed by regression. Results: We identified 202 cases, 34% aged 18-34, 43% aged 35-64 and 23% elderly (>64 years). Median follow-up was 44 months. Elderly patients were more likely to present with ESKD (23.9%) compared with middle-aged (13.7%) and younger adults (2.9%) (chi(2 )11.6, P = 0.002). In patients with independent kidney function at biopsy, there was no difference in outcomes between age groups. Male gender, Black ethnicity, diabetes, histological evidence of chronic renal damage and estimated glomerular filtration rate < 30 ml/min were risk factors for development of ESKD. In this observational study 68.3% of patients received glucocorticoids and 56.9% additional immunosuppression. Conclusion: Elderly patients with IgAV are more likely to have ESKD at presentation, but there is no difference in renal survival between age groups, among those presenting with independent renal function. Renal impairment at biopsy is an independent risk factor for subsequent development of ESKD. There is significant variability in the timing of kidney biopsy and management of these patients among specialist centres. Young adults have outcomes more in keeping with childhood IgAV.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Odontologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dentistry (hsv//eng)

Keyword

IgA vasculitis; Henoch-Schonlein purpura; end stage renal disease (ESKD); elderly; adult

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view